Compass Therapeutics (CMPX) Operating Expenses (2018 - 2026)
Compass Therapeutics (CMPX) posted Operating Expenses of $20.3 million for Q1 2026, up 12.83% sequentially from $18.0 million in Q4 2025, and up 12.99% YoY from $18.0 million in Q1 2025.
Compass Therapeutics (CMPX) Operating Expenses (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Operating Expenses for 9 years, with the latest figure at $20.3 million in Q1 2026.
- Quarterly Operating Expenses rose 12.99% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.2 million (up 19.94% YoY) and the FY2025 annual result came in at $72.8 million, up 26.73% from the prior year.
- Operating Expenses improved to $20.3 million in Q1 2026 per CMPX's latest filing, from $18.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $21.1 million in Q2 2025 and troughed at $7.2 million in Q1 2022.
- A 5-year average of $14.3 million and a median of $13.3 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 115.2% in 2022, then fell 5.33% in 2023.
- Over 5 years, Operating Expenses stood at $12.9 million in 2022, then increased by 19.44% to $15.4 million in 2023, then climbed by 7.67% to $16.6 million in 2024, then gained by 8.54% to $18.0 million in 2025, then grew by 12.83% to $20.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $20.3 million, $18.0 million, and $15.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 26.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.98 Mn |
| Mar 31, 2026 | 20.30 Mn |
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 15.82 Mn |
| Jun 30, 2025 | 21.07 Mn |
| Mar 31, 2025 | 17.97 Mn |
| Dec 31, 2024 | 16.57 Mn |
| Sep 30, 2024 | 12.24 Mn |
| Jun 30, 2024 | 15.90 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Dec 31, 2023 | 15.39 Mn |
| Sep 30, 2023 | 11.93 Mn |
| Jun 30, 2023 | 13.34 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Dec 31, 2022 | 12.89 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 8.99 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 5.85 Mn |